Acerca de AstraZeneca, one of the biggest pharmaceutical and biologics company has chosen CyberArk as a product to manage privileged identities within the enterprise to meet their regulatory and compliance requirements. The scope of this project is to onboard privileged identities on to CyberArk infrastructure and lockdown direct access to these accounts on the target servers.
• Completed pilot for two critical infra applications deployed on 100 servers. On-boarded privileged accounts belonging to 18 teams and locked down direct user access on the target severs.
• Currently in the process of implementing the solution for remaining 2400 servers in scope (80% Windows servers and 20% Unix servers).